SIGA to activate first trial sites for monkeypox therapy in U.K. next week – Bloomberg

seekingalpha2022-08-17

SIGA Technologies (NASDAQ:SIGA), the maker of smallpox therapy TPOXX, plans to start clinical trials for its lead product, activating trial sites in the U.K. for the first-time next week to evaluate ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2260382844?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-08-17 21:47","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2260382844","market":"us","top_or_hot":-1,"title":"SIGA to activate first trial sites for monkeypox therapy in U.K. next week – Bloomberg","media":"seekingalpha","content":"<div>\n<p>SIGA Technologies (NASDAQ:SIGA), the maker of smallpox therapy TPOXX, plans to start clinical trials for its lead product, activating trial sites in the U.K. for the first-time next week to evaluate ...</p>\n\n<a href=\"https://seekingalpha.com/news/3874149-siga-gains-as-uk-trials-for-monkeypox-therapy-start-next-week\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SIGA to activate first trial sites for monkeypox therapy in U.K. next week – Bloomberg</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSIGA to activate first trial sites for monkeypox therapy in U.K. next week – Bloomberg\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-17 21:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3874149-siga-gains-as-uk-trials-for-monkeypox-therapy-start-next-week><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SIGA Technologies (NASDAQ:SIGA), the maker of smallpox therapy TPOXX, plans to start clinical trials for its lead product, activating trial sites in the U.K. for the first-time next week to evaluate ...</p>\n\n<a href=\"https://seekingalpha.com/news/3874149-siga-gains-as-uk-trials-for-monkeypox-therapy-start-next-week\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4583","symbol_name":"猴痘概念","start_time":0,"source_url":"https://seekingalpha.com/news/3874149-siga-gains-as-uk-trials-for-monkeypox-therapy-start-next-week","article_id":"2260382844","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2260382844","pubTimestamp":1660744039,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"SIGA Technologies (NASDAQ:SIGA), the maker of smallpox therapy TPOXX, plans to start clinical trials","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4583":"猴痘概念","BK4007":"制药","SIGA":"SIGA Technologies Inc"},"translate_title":"SIGA激活英国猴痘治疗的第一个试验点。下周--彭博社","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SIGA":1},"content_text":"SIGA Technologies (NASDAQ:SIGA), the maker of smallpox therapy TPOXX, plans to start clinical trials for its lead product, activating trial sites in the U.K. for the first-time next week to evaluate the treatment against the related monkeypox virus Bloomberg reported Wednesday.   During an interview, SIGA's (SIGA) Chief Scientific Officer Dennis E. Hruby said that the U.K. studies would represent the first of a dozen clinical trial sites to be activated globally in the latest monkeypox outbreak. According to Our World in Data, monkeypox has led to over 38,000 cases in the recent outbreak. The U.S. has reported more than 12,600 monkeypox cases as of Aug. 16, the data from the Centers for Disease Control and Prevention (CDC) indicates. TPOXX is currently available in the U.S. as a treatment for smallpox on a case-by-case basis under the FDA's Expanded Access program.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2260382844"}